Bayview Pharmacy is pleased to present a specialized compounded formulation of Azelastine Hydrochloride 0.175%/Ketotifen 0.05%/Mometasone Furoate 0.06% Nasal Spray. This unique formulation is specifically designed to address various disease states, including allergic rhinitis, perennial rhinitis, and vasomotor rhinitis.

Azelastine Hydrochloride is an antihistamine that functions by inhibiting the action of histamine, a substance in the body that triggers allergic symptoms. Ketotifen is an anti-allergic agent that operates by blocking the release of histamine and other substances that provoke allergic reactions. Mometasone Furoate is a corticosteroid that functions by reducing inflammation in the nasal passages.

This combination of medications is engineered to provide relief from the symptoms of allergic rhinitis, perennial rhinitis, and vasomotor rhinitis, including sneezing, runny nose, nasal congestion, and itchy eyes. Additionally, this formulation is designed to minimize the risk of developing complications from these conditions, such as sinusitis and ear infections.

The nasal spray is a liquid formulation delivered in a spray form, specifically designed for administration into the nasal cavity. This method of delivery ensures targeted local or systemic effects through the nostrils, providing effective relief from symptoms.

If you have any queries about this formulation or how it can assist in treating your condition, please do not hesitate to contact us at Bayview Pharmacy. We are committed to helping you find the most suitable treatment option for your needs.

This compounded formulation of Azelastine Hydrochloride 0.175%/Ketotifen 0.05%/Mometasone Furoate 0.06% Nasal Spray is a liquid formulation delivered in a spray form, specifically designed for administration into the nasal cavity. It is indicated for the treatment of allergic rhinitis and nasal polyps. The active ingredients work synergistically to alleviate symptoms and reduce inflammation.

Azelastine Hydrochloride is an antihistamine that functions by blocking the action of histamine, a substance in the body that triggers allergic symptoms. Ketotifen is an anti-allergic agent that works by inhibiting the release of histamine from mast cells, further reducing allergic reactions. Mometasone Furoate is a corticosteroid that reduces inflammation in the nasal passages, providing relief from swelling and congestion.

It's important to note that this formulation may interact with other medications, including other antihistamines, corticosteroids, and anticholinergics. Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter medications, vitamins, and herbal supplements. Additionally, patients should disclose any allergies they may have to any of the ingredients in this formulation.

This formulation is not recommended for use if you are pregnant or breastfeeding, as it may cause harm to the fetus or infant. It is also contraindicated for patients with a history of glaucoma, cataracts, or other eye problems.

Patients should use this formulation as directed by their healthcare provider. It is crucial not to use more or less of this formulation than prescribed, and not to use it for longer than prescribed. Avoid getting this formulation in your eyes, mouth, or nose. If you have any questions about this formulation, please consult with your healthcare provider.

Azelastine Hydrochloride 0.175%/Ketotifen 0.05%/Mometasone Furoate 0.06% Nasal Spray is a compounded medication specifically designed to alleviate the symptoms associated with allergic rhinitis. This includes symptoms such as sneezing, a runny nose, and itchy or watery eyes. The medication works by inhibiting the action of certain natural substances in the body that trigger allergy symptoms.

Azelastine Hydrochloride is an antihistamine that works by blocking the action of histamine, a substance in the body that triggers allergy symptoms. Ketotifen is an anti-allergy medication that also blocks the action of histamine, along with other substances that trigger allergy symptoms. Mometasone Furoate is a corticosteroid that works by reducing inflammation in the nasal passages.

This medication is delivered in a liquid formulation via a nasal spray, designed for administration directly into the nasal cavity. This allows for targeted local or systemic effects through the nostrils. The medication is typically administered once or twice a day, as prescribed by a healthcare professional.

It is crucial to use this medication exactly as prescribed by your healthcare provider. Do not use more or less of it, or use it more frequently than prescribed. If a dose is missed, it should be used as soon as remembered. However, if it is nearly time for the next dose, the missed dose should be skipped, and the next dose should be taken at the scheduled time. A double dose of this medication should not be used.

Some potential side effects of this medication include headaches, a sore throat, and nosebleeds. If any of these side effects are experienced, it is recommended to contact a healthcare provider. If you have any questions or concerns about using Azelastine Hydrochloride 0.175%/Ketotifen 0.05%/Mometasone Furoate 0.06% Nasal Spray, please consult with your healthcare provider.

This compounded formulation of Azelastine Hydrochloride 0.175%, Ketotifen 0.05%, and Mometasone Furoate 0.06% is delivered as a liquid nasal spray. It is specifically designed for administration into the nasal cavity, providing targeted local or systemic effects through the nostrils. This formulation is indicated for the treatment of various conditions including seasonal and perennial allergic rhinitis, rhinoconjunctivitis, chronic rhinosinusitis, nasal polyps, and asthma.

However, it is crucial to note that this formulation is not indicated for the treatment of acute bronchospasm or status asthmaticus. It should also not be used in patients with known hypersensitivity to any of the components of the formulation.

The formulation is available as a metered-dose nasal spray and should be administered as two sprays per nostril once daily. Patients should be instructed to prime the pump before the first use by actuating the pump 8 times. If the product has not been used for more than 14 days, the pump should be primed again with 1 spray or until a fine mist appears. Patients should be advised to avoid spraying the product in their eyes and to discard the bottle after 120 sprays have been used.

If you have any questions about the use of this formulation, please reach out to us at Bayview Pharmacy. We are here to assist you with any queries or concerns you may have regarding this medication.